UBS Group AG - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$88
-98.4%
63
-98.3%
0.00%
Q2 2023$5,606
-78.3%
3,814
-75.7%
0.00%
Q1 2023$25,889
+225.3%
15,690
+176.0%
0.00%
Q4 2022$7,959
-38.8%
5,685
-32.7%
0.00%
Q3 2022$13,0008,445
+20007.1%
0.00%
Q2 2022$0
-100.0%
42
-99.4%
0.00%
Q1 2022$17,000
-76.4%
6,984
-42.1%
0.00%
Q4 2021$72,000
+227.3%
12,064
+259.0%
0.00%
Q3 2021$22,000
+100.0%
3,360
+430.0%
0.00%
Q4 2020$11,000
-79.2%
634
-83.2%
0.00%
Q3 2020$53,000
+130.4%
3,779
-16.4%
0.00%
Q2 2020$23,0004,5220.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders